内部人交易记录
首席执行官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Shah Prem S, 首席执行官. Officer active across 1 company, notably CVS HEALTH Corp. Cumulatively, 22 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €2.3m. History available since 21 February 2022. The latest transaction was disclosed on 31 March 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Shah Prem S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
25,062 股@ US$71.8222.3% 占其流量Common Stock (Restricted)SEC:0000064803-26-000043:0
1,484 股@ US$72.491.3% 占其流量Common StockSEC:0000064803-26-000043:1
247 股@ US$80.130.2% 占其流量Common StockSEC:0000064803-26-000002:0
6,995 股@ US$73.155.9% 占其流量Common StockSEC:0001127602-25-021076:0
1,308 股@ US$67.981.5% 占其流量Common StockSEC:0001127602-25-011436:0
846 股@ US$62.210.9% 占其流量Common StockSEC:0001127602-25-009804:0
2,653 股@ US$79.563.7% 占其流量Common StockSEC:0001127602-24-012258:0
261 股@ US$76.430.3% 占其流量Common StockSEC:0001127602-24-007467:0
29,473 股@ US$76.9539.5% 占其流量Common StockSEC:0001127602-24-005449:0
13,313 股0Common StockSEC:0001127602-24-005070:0
3,508 股@ US$65.174.0% 占其流量Common StockSEC:0001127602-23-023583:0
3,221 股@ US$74.314.1% 占其流量Common StockSEC:0001127602-23-012254:0
226 股@ US$85.770.3% 占其流量Common StockSEC:0001127602-23-007960:0
20,376 股0Common Stock (RSU)SEC:0001127602-22-022028:0
00Common Stock (RSU)SEC:0000947871-22-000731:0
20,671 股0Common Stock (RSU)SEC:0001127602-22-016899:0
845 股@ US$62.210.7% 占其流量Common StockSEC:0001127602-22-011910:0
18,747 股@ US$101.0923.0% 占其流量Common StockSEC:0001127602-22-011635:0
5,346 股@ US$102.266.6% 占其流量Common StockSEC:0001127602-22-010749:0
1,689 股@ US$106.652.2% 占其流量Common StockSEC:0001127602-22-009964:0
226 股@ US$104.300.3% 占其流量Common StockSEC:0001127602-22-007429:0
47,640 股0Common StockSEC:0001127602-22-006310:0
About Shah Prem S
Shah Prem S is Directeur Général, Co-Président du Retail at CVS HEALTH Corp (XNAS) and is also EVP and Group President at CVS HEALTH Corp. The record shows 22 filings in total, and across the 22 sampled filings the sell amount is EUR 2268471 between 2022-02-23 and 2026-04-02, with the modal transaction nature listed as Retenue fiscale.